|
|
|
|
| |
|
|
|
Welcome to Bard Peripheral Vascular where
a tradition of vascular innovation spans decades
of focusing on improving the quality of patients
lives.
From
C. R. Bards first arterial prosthesis developed
in 1954, Bard and the division of Bard Peripheral
Vascular have demonstrated commitment to innovative
medical technology by introducing surgical and
interventional devices for peripheral vascular
patency, while providing exceptional service and
support to surgeons, interventionalists and radiologists.
The first commercially available
ePTFE graft (expanded polytetraflouroethylene)
was used for AV access, introduced by IMPRA†,
Inc. in 1975. ePTFE is used in vascular prosthetic
applications like grafts, which are commonly used
to surgically bypass diseased arteries or to provide
blood access for hemodialysis. ePTFE can also
be used to cover stents, is readily accepted by
body tissue, pliable, is easily sutured. It has
an excellent history as an implant material in
many applications.
Since
then, an impressive track record of medical device
innovations has kept Bard in the forefront of vascular innovations:
|
|
| |
|
|
| |
|
| |
† Bard, IMPRA, Simon Nitinol
Filter, Carboflo, Distaflo, Recovery and Recovery Cone
are registered
trademarks of C. R. Bard, Inc., or an affiliate.
Flex, CenterFlex, Venaflo, Memotherm, Centurion, Memotherm-FLEXX,
Luminexx, Conquest, Fluency,
Conformexx, Atlas and PerforMAXX are trademarks of C.
R. Bard, Inc., or an affiliate.
Copyright 2004 C. R. Bard, Inc. All rights reserved.
Terms of Use — Privacy Policy |
|
|
|
|
|